Theratechnologies (NASDAQOTH:THERF)

CAPS Rating: No stars

Caps

How do you think THERF will perform against the market?

Add Stock to CAPS Watchlist

All Players

8 Outperform
0 Underperform
 

All-Star Players

1 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top THERF Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TSIF (99.98)
Submitted May 25, 2010

Theratechnologies got more bad news today, courteous of the FDA, that sent it's shares down 54% today (5/25/10). Theratechnologies is a Canadian Based company and you can learn more about it at ticker symbol TH.TO The PK version being sparser volume.… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

THERF VS S&P 500 (SPY)

THERF Summary

Recent Community Commentary

Read the most recent pitches from players about THERF.

Recs

0
Member Avatar JFLETCH (< 20) Submitted: 5/27/2018 10:50:35 PM : Outperform Start Price: $10.92 THERF Score: -38.33

Massive growth from sales of recently FDA approved drug Trogarzo.

Recs

0
Member Avatar JohnBelg (82.66) Submitted: 7/27/2017 10:03:30 AM : Outperform Start Price: $6.30 THERF Score: +1.22

Phase III drug ibalizumab for multi-drug resistant HIV. Granted Priority Review, Breakthrough Therapy and Orphan Drug status by FDA. About $462 million market cap so fairly unknown at prsent.

Recs

0
Member Avatar Fiscaldrone (64.78) Submitted: 6/14/2010 9:53:50 PM : Outperform Start Price: $5.06 THERF Score: -113.06

FDA approval of Tesamoralin passed. Hired management with track record to produce new product into the market place in late October 2010

Leaderboard

Find the members with the highest scoring picks in THERF.

Score Leader

TSIF

TSIF (99.98) Score: +144.34

I caught Theratechnologies on a short, but steep drop caused by safety concerns on its aids related drug. The drug did pass and THTCF is looking to list on the NASDAQ and go into production. 3/11

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
tyler1952 < 20 8/15/2018 Outperform 3Y $6.78 +8.11% +0.95% +7.16 0 Comment
cmendress < 20 5/7/2009 Outperform 3Y $2.33 +215.27% +212.71% +2.56 1 Comment
JohnBelg 82.66 7/27/2017 Outperform 5Y $6.30 +16.33% +15.11% +1.22 1 Comment
JFLETCH < 20 5/29/2018 Outperform 5Y $10.92 -32.88% +5.46% -38.33 1 Comment
Munchenman77 52.44 12/3/2009 Outperform 5Y $3.56 +105.90% +155.54% -49.65 0 Comment
bigbonesmagoo 28.97 10/18/2010 Outperform 5Y $4.60 +59.33% +142.11% -82.78 0 Comment
GBPackerfanz 55.44 9/2/2010 Outperform 5Y $4.70 +55.96% +161.76% -105.81 0 Comment
Fiscaldrone 64.78 6/14/2010 Outperform 5Y $5.06 +44.86% +157.93% -113.06 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for THERF.

Featured Broker Partners


Advertisement